The DOI matches its Crossref record; the references it cites are not checked yet.
Nonenzymatic Asn Deamidation of GAD65 Generates HLA-DRB1*03:01–Restricted Neoepitopes in Type 1 Diabetes
Abstract
GAD65-reactive antibodies are common in individuals with DRB1*03:01 haplotypes and diabetes, and benefits from GAD65 therapy are linked to DRB1*03:01 genotypes. DRB1*03:01 prefers Asp in binding pocket 4, such that Asn deamidation, a modification documented in islets, could generate neoepitopes. DRB1*03:01 should present GAD65 epitopes, but few have been reported. We aimed to identify DRB1*03:01-restricted GAD65 epitopes recognized in individuals with type 1 diabetes (T1D). We defined wild-type and Asn-deamidated GAD65 epitopes that are bound by DRB1*03:01 and assessed their immunogenicity through in vitro T-cell assays. In total, three deamidated and four unmodified GAD65 peptides elicited detectable T-cell responses in individuals with T1D. T-cell clones and lines recognizing each GAD65 epitope were isolated and studied, demonstrating that Asn-deamidated GAD65 epitopes are recognized with higher affinity than unmodified GAD65 epitopes. Furthermore, islet-derived T cells from pancreatic organ donors with T1D recognized Asn-deamidated and unmodified GAD65 epitopes. In total, our work identifies wild-type and deamidated epitopes that drive GAD65-specific T-cell responses in individuals positive for DRB1*03:01. These epitopes can now be applied to characterize GAD65-specific T-cell responses during diabetes progression and in the setting of clinical trials. Article Highlights: DRB1*03:01 is associated with GAD65 autoantibodies and immune modulation with GAD65 protein, but few reliable epitopes have been reported. We aimed to identify relevant GAD65 epitopes recognized in individuals positive for DRB1*03:01. We identified regions of GAD65 that are recognized by CD4+ T cells in individuals with DRB1*03:01 haplotypes and type 1 diabetes, including wild-type and Asn-deamidated epitopes. T cells recognized deamidated GAD65 with higher affinity than wild-type GAD65. GAD65-specific T cells are present among islet-derived T cells from pancreatic organ donors, suggesting a direct role in islet autoimmunity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Metadata
- Authors
- Callebaut, A., Jones, A. R., Manganaro, A., Velarde de la Cruz, E. E., Mathieu, C., Overbergh, L., Kent, S. C., & James, E. A.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2026-11-16
- ISSN
- 0012-1797
- 1939-327X
- Cited by
- 0
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Nonenzymatic Asn Deamidation of GAD65 Generates HLA-DRB1*03:01–Restricted Neoepitopes in Type 1 Diabetes. https://app.cochat.ai/papers/10.2337/db26-0296
- The paper
- Callebaut, A., Jones, A. R., Manganaro, A., Velarde de la Cruz, E. E., Mathieu, C., Overbergh, L., Kent, S. C., & James, E. A. (2026). Nonenzymatic Asn Deamidation of GAD65 Generates HLA-DRB1*03:01–Restricted Neoepitopes in Type 1 Diabetes. Diabetes. https://doi.org/10.2337/db26-0296
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.